In The Press September 08, 2021

Time to Heed OIG Guidance on Rx Discounts (Specialty Pharmacy Continuum)

Pharmaceutical manufacturers looking to help patients gain access to expensive drug and medical treatments need to tread lightly and heed guidance from the Department of Health and Human Services’ Office of Inspector General (OIG), according to panelists speaking at Informa Connect’s 2021 Compliance Congress for Specialty Products. However, manufacturers are aware that waiving patient cost shares can provide more immediate access to therapies, as well as encourage adherence to medications, said Goodwin Healthcare and Life Sciences partner Matthew Wetzel. Read the Specialty Pharmacy Continuum article here.